Unlisted stock broker in india

Blog

Lakeshore Hospital & Research Centre Limited

Lakeshore Hospital & Research Centre Limited Unlisted Share – Company Overview

Establish on 04 April 1996 Lakeshore Hospital and Research Centre Limited is a Public incorporated Company. It is classified as a Non-govt Company and is registered at the Registrar of Companies, Ernakulam. Its authorized share capital is Rs. 1,000,000,000 and its paid up capital is Rs. 1,000,000,000.

VPS Lakeshore, one of the largest, most comprehensive, independent multi-specialty hospitals in Kerala is recognized as a leader in medical education, groundbreaking research, and innovative, patient-centered clinical care. The hospital has become the hospital of choice for patients worldwide.

The advanced hi-tech healthcare facility offers diverse medical specialties, including Multi-Organ Transplantation, Gastroenterology, G.I Surgery, Medical, Surgical Oncology, Joint Replacement, Accident & Trauma Orthopedics, Sports Medicine, Neurology, Neurosurgery Surgery, Cardiology, Cardiovascular Surgery, Gynecology & more.

The hospital officially opened its doors to integrated healthcare. Over the years, the hospital has emerged as a center of international healthcare excellence for patients in India & abroad through a broad range of advanced clinical programs and the most cutting-edge treatments and diagnostic services.

Lakeshore Hospital & Research Centre Limited Incorporation Details

CIN of Lakeshore Hospital and Research Centre

U85110kl1996plc010260

Registration Date of Lakeshore Hospital and Research Centre

 

 4/4/1996

Category/Sub-category of Lakeshore Hospital and Research Centre

Company limited by Shares

Registration Number of Lakeshore Hospital and Research Centre

10260

Lakeshore Hospital and Research Centre Registered office address & contact details

No XVI/612, KANAYANNUR TALUK, MARADU, NETTOOR.P.O,

KOCHI – 682040, KERALA

Ph No- +91-484-2701032  

Lakeshore Hospital and Research Centre Registrar & Transfer Agent address & contact details

Integrated Registry Management Services (P) Ltd 2ndFloor, ‘Kences Towers’, No.1, Ramakrishna Street, North Usman Road, T.Nagar, Chennai-600017

Phone: 044 28140801,28140803

Lakeshore Hospital & Research Centre’s Particulars of Holding, Subsidiary & Associate Companies

S.NO.Name Of The CompanyCategory%Of Shares Held
1.Lakeshore Food and Beverages Private LtdSubsidiary100%

Lakeshore Hospital & Research Centre Limited Board of Directors

S.NO.Name of the DirectorsCategory
1.Dr. Shamsheer V.PChairman & Managing Director
2.Mr. P.M. SebastianVice Chairman
3.Mr. K.N.P NairDirector
4.Dr. K.V. JohnyDirector
5.Mr. P.D MathewDirector
6.Mr. A .Janardhana PaiIndependent Non-Executive Director
7.Mr. M.M. MathaiDirector
8.Mr. Job VargheseDirector
9.Dr. K ChitratharaWoman Director

Lakeshore Hospital & Research Centre’s Principal Business Activities

Name & Description of main products/servicesNIC Code of the Product /service% of total turnover of the company
Hospital Activities8610100%

Lakeshore Hospital & Research Centre Limited Shareholding Pattern (As on 31-03-2022)

S. No.Shareholder’s CategoryNo. of Shares% of total Shares of the company
1.Directors5677722556.78
2.Director’s Relatives2097067820.97
3.Body Corporate13955021.40
4.Resident Indians1364390713.64
5.Employee5760000.58
6.Non Resident Members66366886.64
Total100000000100.00

Industry Outlook

During the reporting year, the healthcare sector was impacted due to COVID-19. Meanwhile, the Company was able to overcome the challenging phase of the pandemic with effective cost control measures.

During the year, total income from operations was `244.42 crores compared to `306.63 crores. The profit for the year was `7.75 crores as compared to `16.44 crores. The Board of Directors recommended a dividend of 5% to the shareholders subject to the approval of the ensuing Annual General Meeting.

During the year under report, The company has provided health care delivery to 126137 patients under the out-patient category and 9721 patients under the in-patient category.

The Company spent `37 lakhs on CSR activities during the financial year which concluded on 31st March 2021. It was spent on preventive healthcare, sanitation, prevention, and COVID-related expenditure. The Company also provided concession in treatment charges to the tune of `3.56 crores to the needy and economically backward patients during the reporting year.

Lakeshore Hospital And Research Centre Limited Balance Sheet (Rs. In Lakhs)

PARTICULARS 31 March 2023 31 March 2022
ASSETS  
Non-current assets  
Property, Plant and Equipment32,764.3834,051.02
Capital work-in-progress567.2615.29
Other Intangible assets44.0952.97
Right-of-use assets423.4479.82
Financial Assets  
Other financial assets1,321.661,938.63
Non-current tax assets (net)458.65592.53
Other non-current assets155.15216.47
 35,734.5937,346.73
Current assets  
Inventories1,271.851,106.15
Financial Assets  
Trade receivables1,998.892,013.45
Cash and cash equivalents3,663.151,162.36
Bank balances other than (ii) above6,178.193,898.73
Loans5.586.64
Other financial assets986.13669.99
Other current assets187.33190.26
 14,291.129,047.58
Total Assets50,025.7146,394.31
EQUITY AND LIABILITIES  
Equity :  
Equity Share capital10,000.0010,000.00
Other Equity27,344.9223,121.22
 37,344.9233,121.22
Liabilities :  
Non-current liabilities  
Financial Liabilities  
Borrowings723.561,300.95
Lease liabilities427.46472.04
Other financial liabilities841.83
Provisions1,102.091,070.88
Deferred tax liabilities (Net)1,980.751,619.83
Other non-current liabilities327.02333.26
 4,560.885,638.79
Current liabilities  
Financial Liabilities  
Borrowings578.85578.85
Lease liabilities54.4751.5
Trade payables  
Total outstanding dues of micro enterprises and small enterprises106.11138.52
Total outstanding dues of creditors other than micro enterprises and small enterprises3,433.273,181.46
Other financial liabilities3,521.043,295.28
Other current liabilities318.21295.52
Provisions107.9693.17
 8,119.917,634.30
Total Equity and Liabilities50,025.7146,394.31

 

Lakeshore Hospital And Research Centre Limited Profit & Loss Statement (Rs. In Lakhs)

PARTICULARS 31 March 2023 31 March 2022
Income:  
Revenue from operations41,918.4235,858.70
Other income535.62307.11
Total Income42,454.0436,165.81
Expenses:  
Purchase of Medicines & Consumables11,170.4910,251.14
Changes in inventories of Medicines & Consumables-165.7-186.46
Employee benefits expense6,383.506,282.48
Finance costs211.01257.3
Depreciation and amortisation expense2,269.192,146.15
Other expenses14,344.0911,337.27
Total expenses34,212.5830,087.88
Profit before tax8,241.466,077.93
Tax expense:  
Current tax2,660.931,520.99
Tax for earlier years17.097.93
Deferred tax-188.44260.94
 2,489.581,789.86
Profit for the year5751.884288.07
Other comprehensive income  
Items that will not be reclassified to profit or loss  
Remeasurements of post employment benefit obligations-39.76-187.59
Income tax relating to items that will not be reclassified to profit or loss11.5854.63
Total other comprehensive income for the year-28.18-132.96
Total Comprehensive Income for the year5,723.704,155.11
Earnings per equity share of Rs 10 each:  
Basic (`)5.754.29
Diluted (`)5.754.29

 

Lakeshore Hospital And Research Centre Limited Consolidated Cash Flow Statement (Rs. In Lakhs)

Particulars 31 March 2023 31 March 2022
Cash flow from operating activites  
Profit before tax8,201.705,890.34
Adjustments for :  
Depreciation and amortisation2,269.192,146.15
Interest expense211.01257.3
Interest income-416.18-168.7
Net (Profit)/ Loss on sale/write off of Property Plant and Equipment67.08237.38
Government grant income-37.44-23.34
Bad debts and advances written off
Provision for doubtful debts1,098.86400
Operating cash flow before working capital changes11,394.228,739.13
Movements in working capital :  
(Increase) / decrease in inventories-165.7-186.46
(Increase) / decrease in trade and other receivables-2,872.51-5,629.77
Increase / (decrease) in trade and other payables-876.041,211.64
 7,479.974,134.54
Direct taxes paid net of refunds-1,983.24-1,015.20
Net cash flows from operating activities (A)5,496.733,119.34
Cashflow from investing activities  
Additions to Property, Plant & Equipment (including capital work in progress)-903.62-2,645.57
Investment in subsidiaries
Sale or withdrawal of property, plant and equipment9.19124.33
Interest received229.75117.51
Net cash flows from investing activites (B)-664.68-2,403.73
Cashflow from financing activities  
Proceeds/(Repayment) of Buyers credit/ Term Loan-577.39-1,841.69
Movement in Short term borrowings (Net)
Dividend paid-1,500.67-497.72
Dividend distribution tax paid
Payment of lease liabilities-83.86-73.81
Interest paid-169.34-225.84
Net cash flows from financing activities (C)-2,331.26-2,639.06
Net Increase in Cash & Cash Equivalents (A)+(B)+(C)2,500.79-1,923.45
Cash and cash equivalent at the beginning of the Year1,162.363,085.81
Cash and cash equivalent at the end of the Year  
Cash on hand23.2230.79
Balance with Banks in current account and deposit account3,639.931,131.57
Cash and cash equivalents3,663.151,162.36
Net increase/(decrease) in Cash and Cash equivalents2,500.79-1,923.45

Let ‘s break down the Cash Flow Statement for the years 2023 and 2022, activity-wise:

1. Cash Flow from Operating Activities:

   – This section begins with the profit before tax, which indicates the company ‘s earnings before tax deductions.

   – Adjustments are made for non-cash expenses like depreciation and amortization, as well as for interest expenses and income.

   – The net profit or loss from the sale or write-off of Property, Plant, and Equipment is accounted for here, along with any government grant income.

   – After these adjustments, the operating cash flow before working capital changes is calculated.

   – Movements in working capital, such as changes in inventories, receivables, and payables, are then factored in.

   – Direct taxes paid, net of refunds, are deducted to arrive at the net cash flows from operating activities.

2. Cash Flow from Investing Activities:

   – This section covers cash flows related to investments in assets and securities.

   – Additions to Property, Plant & Equipment (PPE) are recorded as cash outflows.

   – Any investments made in subsidiaries are also noted.

   – Cash received from the sale or withdrawal of PPE and interest income earned are included.

   – The net cash flows from investing activities are calculated by subtracting cash outflows from cash inflows.

3. Cash Flow from Financing Activities:

   – Financing activities involve cash flows related to raising and repaying capital.

   – Proceeds from or repayments of buyers ‘ credit or term loans are recorded, along with any changes in short-term borrowings.

   – Dividends paid to shareholders and any dividend distribution tax are accounted for as cash outflows.

   – Payments of lease liabilities and interest paid are also included.

   – The net cash flows from financing activities are calculated by summing up cash inflows and outflows.

4. Net Increase in Cash & Cash Equivalents:

   – This section calculates the overall change in cash and cash equivalents during the period.

   – It adds the net cash flows from operating, investing, and financing activities to determine the total increase or decrease in cash.

   – The cash and cash equivalents at the beginning of the year are added to this total to find the ending balance of cash and cash equivalents.

5. Cash and Cash Equivalents at the Beginning and End of the Year:

   – The cash and cash equivalents at the beginning of the year provide the starting point for the analysis.

   – The ending balance of cash and cash equivalents is calculated by adding the net increase or decrease in cash to the beginning balance.

Financial Ratios of Lakeshore Hospital And Research Centre Limited:

Particulars20232022
(a) Current Ratio1.761.19
(b) Debt-Equity Ratio0.030.06
(c) Debt Service Coverage Ratio9.837.81
(d) Return on Equity Ratio0.160.14
(e) Inventory Turnover Ratio9.269.94
(f) Trade Receivables Turnover Ratio20.8918.74
(g) Trade Payables Turnover Ratio3.263.10
(h) Net Capital Turnover Ratio6.7925.37
(i) Net Profit Ratio0.140.12

Insights into the financial health and performance of the company in 2023 and 2022:

(a) Current Ratio:

   – The current ratio measures a company ‘s ability to pay its short-term obligations with its short-term assets.

   – In 2023, the current ratio is 1.76, indicating that the company has 1.76 times more current assets than current liabilities.

   – In 2022, the current ratio was lower at 1.19, suggesting a potential improvement in the company ‘s liquidity position over the year.

(b) Debt-Equity Ratio:

   – The debt-equity ratio compares a company ‘s total debt to its shareholders ‘ equity.

   – In 2023, the ratio is 0.03, indicating that the company ‘s debt is very low compared to its equity.

   – Similarly, in 2022, the ratio was slightly higher at 0.06, suggesting a slight increase in debt relative to equity compared to 2023.

(c) Debt Service Coverage Ratio:

   – The debt service coverage ratio measures a company ‘s ability to cover its debt obligations with its operating income.

   – In 2023, the ratio is 9.83, indicating a strong ability to cover debt payments with operating income.

   – In 2022, the ratio was slightly lower at 7.81, suggesting a relatively weaker coverage of debt payments compared to 2023.

(d) Return on Equity Ratio:

   – The return on equity (ROE) ratio measures the profitability of a company in relation to its shareholders ‘ equity.

   – In 2023, the ROE ratio is 0.16, indicating that the company generated a return of 16% on its shareholders ‘ equity.

   – In 2022, the ratio was slightly lower at 0.14, suggesting a slight decrease in profitability compared to 2023.

(e) Inventory Turnover Ratio:

   – The inventory turnover ratio measures how efficiently a company manages its inventory.

   – In 2023, the ratio is 9.26, indicating that the company turns over its inventory approximately 9.26 times during the year.

   – In 2022, the ratio was slightly higher at 9.94, suggesting a slight decrease in inventory turnover efficiency compared to 2023.

(f) Trade Receivables Turnover Ratio:

   – The trade receivables turnover ratio measures how efficiently a company collects its accounts receivable.

   – In 2023, the ratio is 20.89, indicating that the company collects its receivables approximately 20.89 times during the year.

   – In 2022, the ratio was slightly lower at 18.74, suggesting a slight improvement in receivables turnover efficiency compared to 2023.

(g) Trade Payables Turnover Ratio:

   – The trade payables turnover ratio measures how efficiently a company manages its accounts payable.

   – In 2023, the ratio is 3.26, indicating that the company pays its suppliers approximately 3.26 times during the year.

   – In 2022, the ratio was slightly lower at 3.10, suggesting a slight decrease in payables turnover efficiency compared to 2023.

(h) Net Capital Turnover Ratio:

   – The net capital turnover ratio measures how efficiently a company utilizes its capital to generate revenue.

   – In 2023, the ratio is 6.79, indicating that the company generates revenue of 6.79 times its net capital.

   – In 2022, the ratio was significantly higher at 25.37, suggesting a notable decrease in capital turnover efficiency compared to 2023.

(i) Net Profit Ratio:

   – The net profit ratio measures the profitability of a company in relation to its revenue.

   – In 2023, the net profit ratio is 0.14, indicating that the company generates a net profit of 14% of its revenue.

   – In 2022, the ratio was slightly lower at 0.12, suggesting a slight decrease in profitability compared to 2023.

Dividend History of Lakeshore Hospital And Research Centre Limited:

Particulars2023
Dividend (final + interim) (In Rs.)1.70

 

Annual Reports

Leave a Reply

    Our customer support team is here to answer your questions. Ask us anything!